{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-020005","form_type":"8-K","ticker":"ETON","cik":"0001710340","company_name":"Eton Pharmaceuticals, Inc.","filed_at":"2026-06-09T20:31:00+00:00","discovered_at":"2026-06-09T20:32:00.252399+00:00","generated_at":"2026-06-09T20:34:36.415295+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"high","headline":"Eton Pharmaceuticals reports stockholder voting results from 2026 annual meeting","bullets":["Jenn Adams elected director with 13,370,948 votes for, 2,149,317 withheld.","Charles J. Casamento elected director with 9,925,548 votes for, 5,594,717 withheld.","Ratification of Grant Thornton LLP as auditor passed with 16,942,328 for, 3,236,671 against.","Broker non-votes on director elections totaled 4,664,035."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-020005","json":"https://secwatch.observer/filing/0001437749-26-020005.json","markdown":"https://secwatch.observer/filing/0001437749-26-020005.md","text":"https://secwatch.observer/filing/0001437749-26-020005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/0001437749-26-020005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/eton20260409_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T20:34:36.415295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59a0a8be26f75e880f21e0c35eb87252e8a35226","claim":"Eton Pharmaceuticals, Inc. shareholders voted on Election of Directors at the 2026-06-09 meeting.","evidence_excerpt":"Proposal 1: Election of Directors Nominee For Withheld Broker Non-Votes Jenn Adams 13,370,948 2,149,317 4,664,035 Charles J. Casamento 9,925,548 5,594,717 4,664,035","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/0001437749-26-020005-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"e81a0d037e861ecd6bdc3b060f2768d8eba2d350","claim":"Eton Pharmaceuticals, Inc. shareholders approved Ratification of the Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026 at the 2026-06-09 meeting.","evidence_excerpt":"Proposal 2: Ratification of the Appointment of Grant Thornton LLP as the Company ’ s Independent Registered Public Accounting Firm for the year ending December 31, 2026 For Against Abstain 16,942,328 3,236,671 5,301","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926020005/0001437749-26-020005-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}